Rapport Therapeutics, Inc. RAPP Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Rapport Therapeutics, Inc.’s reported figures.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s free cash flow?
- Rapport Therapeutics, Inc. (RAPP) reported free cash flow of -$13.15M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s free cash flow changed year-over-year?
- Rapport Therapeutics, Inc.'s free cash flow increased by 36.0% year-over-year, from -$20.53M to -$13.15M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.